MAPK8 and familial pancreatic carcinoma: Furthermore, Western blot findings reveal that RP-6306 treatment activates the inflammatory MAPK pathway within pancreatic cancer cells, evidenced by elevated phosphorylation of p38 MAPK, JNK, and ERK (Fig. 3L).